FMT for Refractory IBD Patients

Adult IBD patients with active disease or IBD in remission with a confirmed diagnosis of Crohn’s disease (CD), ulcerative colitis (UC), or IBD-unclassified treated with FMT for rCDI were included. There were no specific exclusion criteria. All eligible patients provided informed consent at the participating centres at the moment of FMT according to local requirements.

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

van Lingen E.(., Baunwall S.(., Lieberknecht S.(., Benech N.(., Ianiro G.(., Sokol H.(., Gasbarrini A.(., Cammarota G.(., Eriksen M.(., van der Meulen-de Jong A.(., Terveer E.(., Verspaget H.(., Vehreschild M.(., Hvas C.(, & Keller J.(. (2023). Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease. Therapeutic Advances in Gastroenterology, 16, 17562848231156285.

Publication 2023

Adult Crohn s disease Diagnosis Patients Ulcerative colitis

Corresponding Organization : Leiden University Medical Center

Other organizations : Aarhus University Hospital, Goethe University Frankfurt, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Centre de Recherche Saint-Antoine, Istituti di Ricovero e Cura a Carattere Scientifico, Università Cattolica del Sacro Cuore, Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine, Groupe Français de Transplantation Fécale, University Hospital Cologne, University of Cologne, Heinrich Heine University Düsseldorf, Düsseldorf University Hospital, German Center for Infection Research, Medisch Centrum Haaglanden

Top 5 similar protocols

Variable analysis

independent variables

Treatment with Fecal Microbiota Transplantation (FMT)

dependent variables

Outcomes in adult IBD patients with active disease or IBD in remission, with a confirmed diagnosis of Crohn's disease (CD), ulcerative colitis (UC), or IBD-unclassified

control variables

No specific exclusion criteria mentioned

controls

No positive or negative controls explicitly mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!